Insights.

One of our experts was lucky enough to attend the annual General Counsel (GC) Summit in Sydney, Australia, in early May. It was a genuinely enthralling event, with senior speakers from a variety of industries walking through their challenges, failures, solutions and lessons learned. We have…

Clinical trial subjects will have new privacy rights with the implementation of the EU’s upcoming data privacy regulation—GDPR.

For many businesses, the acronym GDPR has become synonymous with “greatest operational and legal challenge over the next five years.” In turn, you have probably been targeted with buckshot marketing campaigns introducing solutions that will supposedly save you and your loved ones from impending…

As patients, we expect healthcare providers to keep our personal information safe and secure. We also expect them to make healthcare as accessible as possible. Providers have responded to demand by offering mobile apps, paperless transfer of medical records, online bill payment, and email-based…

One of the core advantages that drives parties to arbitrate is the promise of confidentiality. Unlike court proceedings, which are open to the public, arbitrations provide parties with a private forum through which to air and resolve their disputes.

The new Federal Rule 37(e) governing the imposition of “spoliation sanctions” (i.e., remedial measures that judges may impose against a party for failing to preserve potentially relevant evidence) became effective December 15, 2015.  The rule change was intended to:

Patent portfolios are a fundamental building block, and an important revenue stream, for today’s global companies. The USPTO reported a 10% increase in the number of patents issued from 2012 to 2013, with the total number of assignees increasing by more than 4,000. Among PCT filing countries, China…